share_log

CRISPR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(10.75%)

SEC announcement ·  Jan 30 05:07
Summary by Futu AI
ARK Investment Management LLC, an investment adviser based in Delaware, United States, has filed an amended Schedule 13G with the United States Securities and Exchange Commission on January 29, 2024, indicating a change in their holdings of CRISPR Therapeutics AG common stock. As of December 31, 2023, ARK Investment Management LLC reported beneficial ownership of 8,536,104 shares of CRISPR Therapeutics, representing 10.75% of the class. The filing shows that ARK has sole voting power over 8,057,147 shares and shared voting power over 244,377 shares. Additionally, ARK has sole dispositive power over the entire 8,536,104 shares it holds. The filing was made under Rule 13d-1(b) of the Securities Exchange Act of 1934, which is typically used by passive investors to report their holdings.
ARK Investment Management LLC, an investment adviser based in Delaware, United States, has filed an amended Schedule 13G with the United States Securities and Exchange Commission on January 29, 2024, indicating a change in their holdings of CRISPR Therapeutics AG common stock. As of December 31, 2023, ARK Investment Management LLC reported beneficial ownership of 8,536,104 shares of CRISPR Therapeutics, representing 10.75% of the class. The filing shows that ARK has sole voting power over 8,057,147 shares and shared voting power over 244,377 shares. Additionally, ARK has sole dispositive power over the entire 8,536,104 shares it holds. The filing was made under Rule 13d-1(b) of the Securities Exchange Act of 1934, which is typically used by passive investors to report their holdings.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.